Received: 9 May 2020
Accepted: 4 August 2020
First Online: 24 September 2020
Ethics approval and consent to participate
: This research complied with the guidelines for human studies and was conducted ethically in accordance with the World Medical Declaration of Helsinki. All participants gave their written informed consent to participate in this study, and the study protocol was approved by the Ethics Committee of the University and Pharmacy, Cluj Napoca, Romania (registration number 444).
: Not applicable.
: CP is a former employee of DNAfit Life Sciences; he receives no financial benefits at present from either DNAfit or Prenetics. At the time of the study, and during the writing of the manuscript, he was a full-time employee of DNAfit Life Sciences. SS is an employee of Prenetics, a genetic testing company. KG is Chief Scientific Officer of DNAFit Life Sciences, and is the founder and director of Eurogenetica Ltd. MV uses Eurogenetica tests, among others, in the clinic. LF, AS, DSP, and IP have no competing interests to declare, and receive no financial benefits from either DNAfit or Prenetics.